Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-05T04:08:30.748Z Has data issue: false hasContentIssue false

21 - Regenerative medicine

Published online by Cambridge University Press:  30 October 2009

By
Heather L. Greenwood  and
Abdallah S. Daar
Edited by
Peter A. Singer  and
A. M. Viens
Heather L. Greenwood
Affiliation:
University of Toronta, Canada
Abdallah S. Daar
Affiliation:
Professor University of Toronto, Canada
Peter A. Singer
Affiliation:
University of Toronto
A. M. Viens
Affiliation:
University of Oxford
Get access

Summary

A 56-year-old man with severe angina pectoris visits a cardiac specialist for a consultation. During the course of the examination, the patient excitedly describes a story from the news about an experimental gene therapy that aims to stimulate new blood vessel growth in patients with coronary artery disease. He feels that such therapy could dramatically improve his condition and expresses a strong desire to enroll in the clinical trial. The clinician has some familiarity with the details of the trial and wonders how she should counsel her patient.

A 24-year-old woman with abnormal bladder development and function resulting from spina bifida visits her physician for a routine check-up. The patient would also like to discuss a new therapy she has heard about that involves the growth of a replacement bladder for transplantation using the patient's own cells. This therapy has been successfully applied in a number of other patients with spina bifida. Her physician wonders how to approach the discussion with his patient.

What is regenerative medicine?

Regenerative medicine has been the focus of substantial funding and research efforts worldwide (Attorney General of California, 2004; Greenwood et al., 2006). Additionally, it has engaged public attention through highly publicized political debates (Press, 2006; Wagner, 2006), media accounts of “miracle” cures (Kuntzman, 2004), and strong lobbying from voluntary health organizations (Perry, 2000). As a newly emerging and evolving field, there is to date no consensus definition of regenerative medicine (Mironov et al., 2004).

Type
Chapter
Information
The Cambridge Textbook of Bioethics , pp. 153 - 159
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abouna, G. M. (2003). Ethical issues in organ and tissue transplantation. Exp Clin Transplant 1: 125–38.Google ScholarPubMed
Assisted Human Reproduction Act 2004. Ottawa: Department of Justice.
Atala, A., Bauer, S. B., Soker, S., Yoo, J. J., and Retik, A. B. (2006). Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367: 1241–6.CrossRefGoogle ScholarPubMed
Attorney General of California (2004). Stem Cell Research. Funding. Bonds. State of California. Sacramento, CA: Secretary of State of California.Google Scholar
Burton, K. W. (2005). Cloning in America: the Genetics and Public Policy Center surveys the nation. Genewatch 18: 13–18.Google ScholarPubMed
Commission on Life Sciences (2002). Stem Cells and the Future of Regenerative Medicine. Washington, DC: National Academy Press.Google Scholar
Congress of the United States of America (2006). Stem Cell Research and Enhancement Act of 2005. Washington, DC: Library of Congress.Google Scholar
Cortesini, R. (2005). Stem cells, tissue engineering and organogenesis in transplantation. Transplant Immunol 15: 81–9.CrossRefGoogle ScholarPubMed
Daar, A. S. (2005). Regenerative medicine: a taxonomy for addressing ethical, legal and social issues. In Ethical, Legal and Social Issues in Organ Transplantation, ed. Gutmann, T., Daar, A. S., Sells, R. A., and Land, W.. Munich: PABST, pp. 368–77.Google Scholar
Ellis-Behnke, R. G., Liang, Y. X., You, S. W., et al. (2006). Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci USA 103: 5054–9.CrossRefGoogle Scholar
European Commission (2005). Consultation Paper: Human Tissue Engineering and Beyond: Proposal for a Community Regulatory Framework on Advanced Therapies. Brussels: European Commission, Enterprise and Industry Directorate-General.Google Scholar
Glannon, W. (2006). Neuroethics. Bioethics 20: 37–52.CrossRefGoogle ScholarPubMed
Greenwood, H. L., Thorsteinsdóttir, H., Perry, G., et al. (2006). Regenerative medicine: new opportunities for developing countries. Int J Biotechnol 8: 60–77.CrossRefGoogle Scholar
Haseltine, W. A. (2001). The emergence of regenerative medicine: a new field and a new society. J Regen Med 2: 17.Google Scholar
Haseltine, W. A. (2003). Regenerative medicine 2003: an overview. J Regen Med 4: 15–18.Google Scholar
Hudson, K. L., Scott, J., and Faden, R. (2005). Values in Conflict: Public Attitudes on Embryonic Stem Cell Research. Washington, DC: Genetics and Public Policy Center.Google Scholar
Human Fertilisation and Embryology (Research Purposes) Regulations (2001). London: The Stationery Office for the Office of Public Sector Information.
Isasi, R. M., Knoppers, B. M., Singer, P. A., and Daar, A. S. (2004). Legal and ethical approaches to stem cell and cloning research: a comparative analysis of policies in Latin America, Asia, and Africa. J Law Med Ethics 32: 626–40.CrossRefGoogle ScholarPubMed
Jefferys, D. B. (2003). An overview of recent developments in the European regulation of medicine/medical device combination products. Drug Inform J 37: 39–43.CrossRefGoogle Scholar
Kimmelman, J. (2005). Recent developments in gene transfer: risks and ethics. BMJ 330: 79–82.CrossRefGoogle Scholar
Koh, C. J. and Atala, A. (2004). Tissue engineering, stem cells, and cloning: opportunities for regenerative medicine. J Am Soc Nephrol 15: 1113–25.CrossRefGoogle ScholarPubMed
Kuntzman, G. (2004). Stem cell gal's miracle steps. New York Post, 29 November.Google Scholar
Lanza, R. P., Cibelli, J. B., and West, M. D. (1999). Prospects for the use of nuclear transfer in human transplantation. Nat Biotechnol 17: 1171–4.CrossRefGoogle ScholarPubMed
Lo, B., Zettler, P., Cedars, M. I., et al. (2005). A new era in the ethics of human embryonic stem cell research. Stem Cells 23: 1454–9.CrossRefGoogle ScholarPubMed
MBBNet (2007). http://mbbnet.umn.edu/scmap.html.
McKneally, M. F. and Daar, A. S. (2003). Introducing new technologies: protecting subjects of surgical innovation and research. World J Surg 27: 930–5.CrossRefGoogle ScholarPubMed
Miller, F. G. and Brody, H. (2005). Enhancement technologies and professional integrity. Am J Bioethics 5: 15–17.CrossRefGoogle ScholarPubMed
Mironov, V., Visconti, R. P., and Markwald, R. R. (2004). What is regenerative medicine? Emergence of applied stem cell and developmental biology. Expert Opin Biol Ther 4: 773–81.CrossRefGoogle ScholarPubMed
Nelson, L. (2005). Biosafety law brings stem-cell research to Brazil. Nature 434: 128.CrossRefGoogle ScholarPubMed
Nisbet, M. C. (2004). Public opinion about stem cell research and human cloning. Pub Opin Q 68: 131–54.CrossRefGoogle Scholar
Perry, D. (2000). Patients' voices: the powerful sound in the stem cell debate. Science 287: 1423.CrossRefGoogle ScholarPubMed
Petit-Zeman, S. (2001). Regenerative medicine. Nat Biotechnol 19: 201–6.CrossRefGoogle ScholarPubMed
Press, A. (2006). Stem cell proposal splits Missouri GOP. New York Times, 12 March.Google Scholar
Preti, R. A. (2005). Bringing safe and effective cell therapies to the bedside. Nat Biotechnol 23: 801–4.CrossRefGoogle Scholar
Rizvi, S. A. H. (1999). Ethical issues in transplantation. Transplant Proc 31: 3269–70.CrossRefGoogle ScholarPubMed
Sandel, M. J. (2004). The case against perfection: what'swrong with designer children, bionic athletes, and genetic engineering. Atlantic Month 292: 50–4, 56–60, 62.Google ScholarPubMed
Sohier, J., Vlugt, T. J., Cabrol, N., et al. (2006). Dual release of proteins from porous polymeric scaffolds. J Contr Release 111: 95–106.CrossRefGoogle ScholarPubMed
Solter, D., Beyleveld, D., Friele, M. B., et al. (2003). Embryo Research in Pluralistic Europe. Berlin: Springer.CrossRefGoogle Scholar
UK Department of Health (2005). UK Stem Cell Initiative. London: Government Printing Office (http://www.advisorybodies.doh.gov.uk/uksci/global/italy.htm).Google Scholar
US Food and Drug Administration (2004). Overview of the Office of Combination Products. Rockville, MD: US Food and Drug Administration (http://www.fda.gov/oc/combination/overview.html).Google Scholar
US Food and Drug Administration (2005). Good Tissue Practices Final Rule. Rockville, MD: US Food and Drug Administration.Google Scholar
US Presidential Address (2001). Stem Cell Research. Washington, DC: Government Printing Office (http://www.whitehouse.gov/news/releases/2001/08/20010809-2.html).Google Scholar
Wagner, J. (2006). Stem cell bill could face filibuster. Washington Post, 8 March, B06.Google Scholar
Wolpe, P. R. (2002). Treatment, enhancement, and the ethics of neurotherapeutics. Brain Cogn 50: 387–95.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×